Home > Insider Trading > Filing (0001593968-20-002228)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887247	Adamis Pharmaceuticals Corp	ADMP	Pharmaceutical Preparations (2834)	820429727

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1461753	J. David Marguglio	C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Ste 300 San Diego CA 92130-	Svp And Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-11-18	8,532	$0.41	322,264	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,884	Indirect	By D. Marguglio as custodian for children

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4025 to $0.408, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, anysecurity holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes shares of common stock beneficially owned and shares of common stock issuable upon vesting of restricted stock units previously reported in Table 1 of Form 4.